Alphabetical listing of all products

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Prices
  • 5 mg - 148 EUR
  • 25 mg - 592 EUR
  • 100 mg - 1776 EUR

Regorafenib

Regorafenib is an orally available multi-kinase inhibitor that targets several receptor tyrosine kinases, with IC50 values of 17, 40 and 69 nM for c-KIT, VEGFR2, B-Raf. It is currently being studied in the treatment of multiple tumor types.

catalogue number: R104
synonyms: BAY73-4506
CAS: 755037-03-7
MW: 482.82 g/mol

References
Int J Cancer. 2011 Jul 1;129(1):245-55. PMID: 21170960